Humana cuts 2019 membership forecast for prescription drug plans

Health insurer Humana Inc on Wednesday said it expected a bigger drop in membership for its prescription drug plans in 2019, as it stuck to its pricing plans in an intensely competitive market.

Chinese geneticist reveals another "potential" gene-edited pregnancy

A Chinese scientist at the center of an ethical storm over what he claims are the world's first genetically edited babies said on Wednesday he is proud of his work and revealed there was a second "potential" pregnancy as part of the research.

Former executive at opioid maker Insys to plead guilty

A former executive at Insys Therapeutics Inc is expected to plead guilty on Wednesday to charges that he participated in a scheme to bribe doctors to prescribe the company's opioid drug.

New cases of HIV rise in Eastern Europe, decline in the West

More than 130,000 people were newly diagnosed with HIV last year in Eastern Europe, the highest rate ever for the region, while the number of new cases in Western Europe declined, global public health experts said on Wednesday.

Telemedicine surging in US but still uncommon

(Reuters Health) - Although telemedicine visits have increased sharply in the U.S. in recent years, the vast majority of American adults still receive care from doctors in person rather than via remote technology, a new study suggests.

Teva to recall certain blood pressure medicine in U.S

Teva Pharmaceutical Industries Ltd is recalling certain combinations of blood pressure drug valsartan in the United States following the detection of a probable cancer-causing impurity, the latest global recall of the medicine.

Atrium Health says data of about 2.65 million patients involved in breach

Atrium Health, previously Carolinas HealthCare System, said on Tuesday data of about 2.65 million patients including addresses, dates of birth and social security numbers may have been compromised in a breach at its third-party provider AccuDoc Solutions.

Meditation may help ease veterans' PTSD symptoms

(Reuters Health) - Some veterans may experience a sharper decline in symptoms of post-traumatic stress disorder (PTSD) with meditation-based therapy than with other forms of treatment, a recent study suggests.

Medicine or vice? Socially screened funds struggle to define cannabis industry

The $8 trillion U.S. socially responsible investment industry is grappling with that question as more states approve the recreational use of cannabis, pushing consumption closer to "sin" stocks like alcohol and tobacco that ethically focused investors avoid.

Harsh parenting can be buffered by warm relationships with teachers, peers

(Reuters Health) - - Children whose parents often threaten and criticize them are more likely to become defiant and aggressive, research shows. But these effects can be buffered by warm relationships with teachers and school friends, a new study suggests.

Roche buys U.S. biotech Jecure in race for liver disease drugs

Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat fatty liver disease.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS